[STRASBOURG, France] Dec. 17, 2025— Core Biogenesis is proud to announce that Tony Abboud, chief commercial officer, has been awarded the Alan B. & Jeanette Black Award from the Society of Cosmetic Chemists (SCC).
This award goes to the paper on sustainable formulation technology, and was presented in connection with the SCC’s 79th Annual Scientific Meeting, taking place December 16–17, 2025, in New York City.
Distinctions like the one offered by this award are more important than ever, especially as consumer priorities shift towards more sustainable practices and the rampant "greenwashing" in the industry, where buzzy words like "green" and "natural" can get hurled around with minimal backing in the consumer space.
Tony Abboud and the Alan B. & Jeanette Black Award
Abboud was selected for this honor based on his presentation, “Advancing Sustainable Bioactive Production: Leveraging Plant-Based Systems as Biofactories for the Personal Care Industry.”
“This award underscores our commitment to building a more sustainable and science-driven future for the beauty and personal care industry,” says Abboud. “At Core Biogenesis, we’re translating advanced plant biotechnologies into next-generation actives that not only elevate product performance but also reduce environmental impact across the supply chain.”
As chief commercial officer, Abboud leads the company’s commercial strategy, helping bridging the worlds of biotechnology and beauty.
“The SCC is proud to recognize Abboud’s exceptional contributions to sustainable formulation technology,” comments Erica O’Grady, CEO of the Society of Cosmetic Chemists. “His presentation, ‘Advancing Sustainable Bioactive Production: Leveraging Plant-Based Systems as Biofactories for the Personal Care Industry,’ reflects the type of forward-looking innovation that supports advancing our scientific community and leads the efforts toward a more sustainable future.”
This recognition from the SCC further reinforces Core Biogenesis’ position as a leader in sustainable, biotech-powered ingredients—where efficacy, clinical performance and environmental responsibility converge.
